Evidence map›Paper›PMID 18779359›Full record

ArticleAntimicrobial agents and chemotherapy2008

Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus.

Jonas Lannergård, Christof von Eiff, Gunnar Sander, Tina Cordes, Jochen Seggewiss, Georg Peters, Richard A Proctor, Karsten Becker, Diarmaid Hughes

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Subpopulations in Strains ofAntibiotics (Basel, Switzerland) · 2023
    Review
  8. Article
  9. FunctionalJournal of bacteriology · 2022
    Article
  10. Article
  11. Microbial Musings - November 2021.Microbiology (Reading, England) · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Designer broad-spectrum polyimidazolium antibiotics.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Article
  18. Article
  19. Novel Research Models forFrontiers in microbiology · 2020
    Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jonas LannergårdDepartment of Cell and Molecular Biology, Microbiology Program, The Biomedical Center, Uppsala University, Uppsala, Sweden.
Christof von Eiff
Gunnar Sander
Tina Cordes
Jochen Seggewiss
Georg Peters
Richard A Proctor
Karsten Becker
Diarmaid Hughes

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small-colony variants (SCVs) of Staphylococcus aureus are associated with persistent infections and may be selectively enriched during antibiotic therapy. Three pairs of clonally related S. aureus isolates were recovered from patients receiving systemic antibiotic therapy. Each pair consisted of an isolate with a normal phenotype and an isolate with an SCV phenotype. These SCVs were characterized by reduced susceptibility to gentamicin, reduced hemolytic activity, slow growth, and menadione auxotrophy. Sequencing of the genes involved in menadione biosynthesis revealed mutations in menB, the gene encoding naphthoate synthase, in all three strains with the SCV phenotype. The menB mutations were (i) a 9-bp deletion from nucleotides 55 to 63, (ii) a frameshift mutation that resulted in a premature stop codon at position 230, and (iii) a point mutation that caused the amino acid substitution Gly to Val at codon 233. Fluctuation tests showed that growth-compensated mutants arose in the SCV population of one strain, strain OM1b, at a rate of 1.8 x 10(-8) per cell per generation. Sequence analyses of 23 independently isolated growth-compensated mutants of this strain revealed alterations in the menB sequence in every case. These alterations included reversions to the wild-type sequence and intragenic second-site mutations. Each of the growth-compensated mutants showed a restoration of normal growth and a loss of menadione auxotrophy, increased susceptibility to gentamicin, and restored hemolytic activity. These data show that mutations in menB cause the SCV phenotype in these clinical isolates. This is the first report on the genetic basis of menadione-auxotrophic SCVs determined in clinical S. aureus isolates.

Indexed as

Base SequenceDNA, BacterialDNA PrimersGenes, BacterialHumansMutationOxo-Acid-LyasesPhenotypeStaphylococcal InfectionsStaphylococcus aureusVitamin K 31,4-dihydroxy-2-naphthoyl-CoA synthase, Staphylococcus aureusDNA, BacterialDNA PrimersOxo-Acid-LyasesVitamin K 3

Identifiers

PMID18779359
PMCPMC2573106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.